Mechanisms in the bed nucleus of the stria terminalis involved in control of autonomic and neuroendocrine functions: A review

Current Neuropharmacology

Volumn 11, Issue 2, 2013, Pages 141-159

  Crestani, Carlos C ^a   Alves, Fernando H F ^b   Gomes, Felipe V ^b   Resstel, Leonardo B M ^b   Correa, Fernando M A ^b   Herman, James P ^c  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF CINCINNATI   (United States)

Author keywords

BNST; Cardiovascular function; Extended amygdala; HPA axis; Neurotransmitters; Stress and physical exercise; Vasopressin

Indexed keywords

2 (2 METHOXY 1, 4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 (2 METHOXY 1,4 BENZODIOXAN 2 YL) 2 IMIDAZOLINE; 2 [[2 (2, 6 DIMETHOXYPHENOXY) ETHYL] AMINOMETHYL] 1, 4 BENZODIOXAN; 2 [[2 (2,6 DIMETHOXYPHENOXY)ETHYL]AMINOMETHYL] 1,4 BENZODIOXAN; 4 AMINOBUTYRIC ACID; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL) PHENOXY] PROPYL] AMINO] ETHOXY] SALICYLAMIDE; 5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; ACETYLCHOLINE; BICUCULLINE METHIODIDE; CANNABIDIOL; CARBACHOL; COBALT CHLORIDE; CORTICOTROPIN RELEASING FACTOR; DECAHYDRO 6 PHOSPHONOMETHYL 3 ISOQUINOLINECARBOXYLIC ACID; GLUTAMIC ACID; MUSCIMOL; NEUROTRANSMITTER; NITRIC OXIDE; NORADRENALIN; OXYTOCIN; UNCLASSIFIED DRUG; VASOPRESSIN;

ARTERIAL PRESSURE; AUTONOMIC NERVOUS SYSTEM; BEHAVIOR; BLOOD PRESSURE; BRAIN STEM; CHEMORECEPTOR REFLEX; DYNAMIC EXERCISE; ELECTROSTIMULATION; EXERCISE; FEAR; FOREBRAIN; HUMAN; HYPOTHALAMUS; IMMOBILIZATION STRESS; MAGNOCELLULAR NUCLEUS; MICRODIALYSIS; NERVE CONDUCTION; NEUROENDOCRINE SYSTEM; NEUROTRANSMISSION; NONHUMAN; PHYSIOLOGICAL PROCESS; PRESSORECEPTOR; REVIEW; STRIA TERMINALIS;

EID: 84876707420     PISSN: 1570159X     EISSN: 18756190     Source Type: Journal    
DOI: 10.2174/1570159X11311020002     Document Type: Review

References (209)

1. Johnston, J.B. Further contributions to the study of the evolution of the forebrain. J. Comp. Neurol., 1923, 35(5), 337-481.
2. Alheid, G.F. Extended amygdala and basal forebrain. Ann. N. Y. Acad. Sci., 2003, 985, 185-205.
3. de Olmos, J.S. A cupric-silver method for impregnation of terminal axon degeneration and its further use in staining granular argyrophilic neurons. Brain Behav. Evol., 1969, 2, 213-237.
4. de Olmos, J.S.; Beltamino, C.A.; Alheid, G.F. Amygdala and Extended Amygdala of the Rat: A Cytoarchitectonical, Fibroarchitectonical, and Chemoarchitectonical Survey. In: The Rat Nervous System. Ed. Paxinos, G. 2004, 495-578. Academic Press, Sydney.
5. Dong, H.W.; Petrovich, G.D.; Swanson, L.W. Topography of projections from amygdala to bed nuclei of the stria terminalis. Brain Res. Brain Res. Rev., 2001, 38(1-2), 192-246.
6. Alheid, G.F.; Heimer, L. New perspectives in basal forebrain organization of special relevance for neuropsychiatric disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience, 1988, 27(1), 1-39.
7. de Olmos, J.; Beltamino, C.A.; Alheid, G.F. Amygdala and extended amygdala of the rat: a cytoarchitectonical, fibroarchitectonial and chemoarchitectonical survey. In: Paxinos G, editor. The rat nervous system. third edition. Elsevier: Amsterdam, 2004, pp. 509-603.
8. de Olmos, J.S.; Heimer, L. The concepts of the ventral striatopallidal system and extended amygdala. Ann. N.Y. Acad. Sci., 1999, 877, 1-32.
9. Krettek, J.E.; Price, J.L. Amygdaloid projections to subcortical structures within the basal forebrain and brainstem in the rat and cat. J. Comp. Neurol., 1978, 178(2), 225-254.
10. Bayer, S.A. Neurogenetic and morphogenetic heterogeneity in the bed nucleus of the stria terminalis. J. Comp. Neurol., 1987, 265(1), 47-64.
11. Ju, G.; Swanson, L.W. Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: I. Cytoarchitecture. J. Comp. Neurol., 1989, 280(4), 587-602.
12. Ju, G.; Swanson, L.W.; Simerly, R.B. Studies on the cellular architecture of the bed nuclei of the stria terminalis in the rat: II. Chemoarchitecture. J. Comp. Neurol., 1989, 280(4), 603-621.
13. Dong, H.W.; Petrovich, G.D.; Watts, A.G.; Swanson, L.W. Basic organization of projections from the oval and fusiform nuclei of the bed nuclei of the stria terminalis in adult rat brain. J. Comp. Neurol., 2001, 436(4), 430-455.
14. Dong, H.W.; Swanson, L.W. Organization of axonal projections from the anterolateral area of the bed nuclei of the stria terminalis. J. Comp. Neurol., 2004, 468(2), 277-298.
15. Dong, H.W.; Swanson, L.W. Projections from bed nuclei of the stria terminalis, posterior division: implications for cerebral hemisphere regulation of defensive and reproductive behaviors. J. Comp. Neurol., 2004, 471(4), 396-433.
16. Herman, J.P.; Figueiredo, H.; Mueller, N.K.; Ulrich-Lai, Y.; Ostrander, M.M.; Choi, D.C.; Cullinan, W.E. Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness. Front. Neuroendocrinol., 2003, 24(3), 151-180.
17. Radley, J.J.; Gosselink, K.L.; Sawchenko, P.E. A discrete GABAergic relay mediates medial prefrontal cortical inhibition of the neuroendocrine stress response. J. Neurosci., 2009, 29(22), 7330-7340.
18. Spencer, S.J.; Buller, K.M.; Day, T.A. Medial prefrontal cortex control of the paraventricular hypothalamic nucleus response to psychological stress: possible role of the bed nucleus of the stria terminalis. J. Comp. Neurol., 2005, 481(4), 363-376.
19. Davis, M.; Walker, D.L.; Miles, L.; Grillon, C. Phasic vs sustained fear in rats and humans: role of the extended amygdala in fear vs anxiety. Neuropsychopharmacology, 2010, 35(1), 105-135.
20. Ulrich-Lai, Y.M.; Herman, J.P. Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci., 2009, 10(6), 397-409.
21. Shammah-Lagnado, S.J.; Beltramino, C.A.; McDonald, A.J.; Miselis, R.R.; Yang, M.; de Olmos, J.; Heimer, L.; Alheid, G.F. Supracapsular bed nucleus of the stria terminalis contains central and medial extended amygdala elements: evidence from anterograde and retrograde tracing experiments in the rat. J. Comp. Neurol., 2000, 422(4), 533-555.
22. Vertes, R.P. Differential projections of the infralimbic and prelimbic cortex in the rat. Synapse, 2004, 51(1), 32-58.
23. Li, Y.W.; Dampney, R.A. Expression of Fos-like protein in brain following sustained hypertension and hypotension in conscious rabbits. Neuroscience, 1994, 61(3), 613-634.
24. Potts, P.D.; Polson, J.W.; Hirooka, Y.; Dampney, R.A. Effects of sinoaortic denervation on Fos expression in the brain evoked by hypertension and hypotension in conscious rabbits. Neuroscience, 1997, 77(2), 503-520.
25. Feldman, S.; Conforti, N.; Saphier, D. The preoptic area and bed nucleus of the stria terminalis are involved in the effects of the amygdala on adrenocortical secretion. Neuroscience, 1990, 37(3), 775-779.
26. Roder, S.; Ciriello, J. Contribution of bed nucleus of the stria terminalis to the cardiovascular responses elicited by stimulation of the amygdala. J. Auton. Nerv. Syst., 1993, 45(1), 61-75.
27. Zhu, W.; Umegaki, H.; Suzuki, Y.; Miura, H.; Iguchi, A. Involvement of the bed nucleus of the stria terminalis in hippocampal cholinergic system-mediated activation of the hypothalamo--pituitary--adrenocortical axis in rats. Brain Res., 2001, 916(1-2), 101-106.
28. Koenigs, M.; Grafman, J. The functional neuroanatomy of depression: distinct roles for ventromedial and dorsolateral prefrontal cortex. Behav. Brain Res., 2009, 201(2), 239-243.
29. Reis, D.J.; Doba, N. The central nervous system and neurogenic hypertension. Prog. Cardiovasc. Dis., 1974, 17(1), 51-71.
30. Sullivan, G.M.; Coplan, J.D.; Kent, J.M.; Gorman, J.M. The noradrenergic system in pathological anxiety: a focus on panic with relevance to generalized anxiety and phobias. Biol. Psychiatry, 1999, 46(9), 1205-1218.
31. Zubcevic, J.; Waki, H.; Raizada, M.K.; Paton, J.F. Autonomicimmune- vascular interaction: an emerging concept for neurogenic hypertension. Hypertension, 2011, 57(6), 1026-1033.
32. Earle, M.L.; Pittman, Q.J. Involvement of the PVN and BST in 1K1C hypertension in the rat. Brain Res., 1995, 669(1), 41-47.
33. Somerville, L.H.; Whalen, P.J.; Kelley, W.M. Human bed nucleus of the stria terminalis indexes hypervigilant threat monitoring. Biol. Psychiatry, 2010, 68(5), 416-424.
34. Freedman, L.J.; Cassell, M.D. Distribution of dopaminergic fibers in the central division of the extended amygdala of the rat. Brain Res., 1994, 633(1-2), 243-252.
35. Herkenham, M.; Lynn, A.B.; Little, M.D.; Johnson, M.R.; Melvin, L.S.; de Costa, B.R.; Rice, K.C. Cannabinoid receptor localization in brain. Proc. Natl. Acad. Sci. U. S. A., 1990, 87(5), 1932-1936.
36. Moore, R.Y.; Bloom, F.E. Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu. Rev. Neurosci., 1979, 2, 113-168.
37. Phelix, C.F.; Liposits, Z.; Paull, W.K. Monoamine innervation of bed nucleus of stria terminalis: an electron microscopic investigation. Brain Res. Bull., 1992, 28(6), 949-965.
38. Ruggiero, D.A.; Giuliano, R.; Anwar, M.; Stornetta, R.; Reis, D.J. Anatomical substrates of cholinergic-autonomic regulation in the rat. J. Comp. Neurol., 1990, 292(1), 1-53.
39. Uhl, G.R.; Kuhar, M.J.; Synder, S.H. Enkephalin-containing pathway: amygdaloid efferents in the stria terminalis. Brain Res., 1978, 149(1), 223-228.
40. Vincent, S.R.; Kimura, H. Histochemical mapping of nitric oxide synthase in the rat brain. Neuroscience, 1992, 46(4), 755-784.
41. Walaas, I.; Fonnum, F. Biochemical evidence for glutamate as a transmitter in hippocampal efferents to the basal forebrain and hypothalamus in the rat brain. Neuroscience, 1980, 5(10), 1691-1698.
42. Dunn, J.D.; Williams, T.J. Cardiovascular responses to electrical stimulation of the bed nucleus of the stria terminalis. J. Comp. Neurol., 1995, 352(2), 227-234.
43. Dunn, J.D.; Williams, T.J. Effect of sinoaortic denervation on arterial pressure changes evoked by bed nucleus stimulation. Brain Res. Bull., 1998, 46(4), 361-365.
44. Faiers, A.A.; Calaresu, F.R.; Mogenson, G.J. Factors affecting cardiovascular responses to stimulation of hypothalamus in the rat. Exp. Neurol., 1976, 51(1), 188-206.
45. Ciriello, J.; Janssen, S.A. Effect of glutamate stimulation of bed nucleus of the stria terminalis on arterial pressure and heart rate. Am. J. Physiol., 1993, 265(5 Pt 2), H1516-1522.
46. Gelsema, A.J.; Copeland, N.E.; Drolet, G.; Bachelard, H. Cardiovascular effects of neuronal activation of the extended amygdala in rats. Brain Res., 1993, 626(1-2), 156-166.
47. Zhang, W.; Zhang, N.; Sakurai, T.; Kuwaki, T. Orexin neurons in the hypothalamus mediate cardiorespiratory responses induced by disinhibition of the amygdala and bed nucleus of the stria terminalis. Brain Res., 2009, 1262, 25-37.
48. Choi, D.C.; Furay, A.R.; Evanson, N.K.; Ostrander, M.M.; Ulrich- Lai, Y.M.; Herman, J.P. Bed nucleus of the stria terminalis subregions differentially regulate hypothalamic-pituitary-adrenal axis activity: implications for the integration of limbic inputs. J. Neurosci., 2007, 27(8), 2025-2034.
49. Alves, F.H.; Resstel, L.B.; Correa, F.M.; Crestani, C.C. Bed nucleus of the stria terminalis alpha1- and alpha2-adrenoceptors differentially modulate the cardiovascular responses to exercise in rats. Neuroscience, 2011, 177, 74-83.
50. Crestani, C.C.; Alves, F.H.; Resstel, L.B.; Correa, F.M. The bed nucleus of the stria terminalis modulates baroreflex in rats. Neuroreport, 2006, 17(14), 1531-1535.
51. Crestani, C.C.; Alves, F.H.; Resstel, L.B.; Correa, F.M. The bed nucleus of the stria terminalis modulates exercise-evoked cardiovascular responses in rats. Exp. Physiol., 2010, 95(1), 69-79.
52. Granjeiro, E.M.; Gomes, F.V.; Alves, F.H.; Crestani, C.C.; Correa, F.M.; Resstel, L.B. Bed nucleus of the stria terminalis and the cardiovascular responses to chemoreflex activation. Auton. Neurosci., 2012, 167(1-2), 21-26.
53. Hott, S.C.; Gomes, F.V.; Fabri, D.R.; Reis, D.G.; Crestani, C.C.; Correa, F.M.; Resstel, L.B. Both alpha(1) - and beta(1) - adrenoceptors in the bed nucleus of the stria terminalis are involved in the expression of conditioned contextual fear. Br. J. Pharmacol., 2012, 167(1), 207-221.
54. Nasimi, A.; Hatam, M. The role of the cholinergic system of the bed nucleus of the stria terminalis on the cardiovascular responses and the baroreflex modulation in rats. Brain Res., 2011, 1386, 81-88.
55. Hatam, M.; Nasimi, A. Glutamatergic systems in the bed nucleus of the stria terminalis, effects on cardiovascular system. Exp. Brain Res., 2007, 178(3), 394-401.
56. Crestani, C.C.; Alves, F.H.; Tavares, R.F.; Correa, F.M. Role of the bed nucleus of the stria terminalis in the cardiovascular responses to acute restraint stress in rats. Stress, 2009, 12(3), 268-278.
57. Dampney, R.A. Functional organization of central pathways regulating the cardiovascular system. Physiol. Rev., 1994, 74(2), 323-364.
58. Deck, C.C.; Raya, T.E.; Gaballa, M.A.; Goldman, S. Baroreflex control of heart rate in rats with heart failure after myocardial infarction: effects of captopril. J. Pharmacol. Exp. Ther. 1992, 263(3), 1424-1431.
59. Grassi, G.; Trevano, F.Q.; Seravalle, G.; Scopelliti, F.; Mancia, G. Baroreflex function in hypertension: consequences for antihypertensive therapy. Prog. Cardiovasc. Dis., 2006, 48(6), 407-415.
60. McKitrick, D.J.; Krukoff, T.L.; Calaresu, F.R. Expression of c-fos protein in rat brain after electrical stimulation of the aortic depressor nerve. Brain Res, 1992, 599(2), 215-222.
61. Fluckiger, J.P.; Sonnay, M.; Boillat, N.; Atkinson, J. Attenuation of the baroreceptor reflex by general anesthetic agents in the normotensive rat. Eur. J. Pharmacol., 1985, 109(1), 105-109.
62. Shimokawa, A.; Kunitake, T.; Takasaki, M.; Kannan, H. Differential effects of anesthetics on sympathetic nerve activity and arterial baroreceptor reflex in chronically instrumented rats. J. Auton Nerv. Syst., 1998, 72(1), 46-54.
63. Casada, J.H.; Dafny, N. Responses of neurons in bed nucleus of the stria terminalis to microiontophoretically applied morphine, norepinephrine and acetylcholine. Neuropharmacology, 1993, 32(3), 279-284.
64. Resstel, L.B.; Alves, F.H.; Reis, D.G.; Crestani, C.C.; Correa, F.M.; Guimaraes, F.S. Anxiolytic-like effects induced by acute reversible inactivation of the bed nucleus of stria terminalis. Neuroscience, 2008, 154(3), 869-876.
65. Hollmann, M.; Heinemann, S. Cloned glutamate receptors. Annu. Rev. Neurosci., 1994, 17, 31-108.
66. Aramori, I.; Nakanishi, S. Signal transduction and pharmacological characteristics of a metabotropic glutamate receptor, mGluR1, in transfected CHO cells. Neuron, 1992, 8(4), 757-765.
67. Dingledine, R.; Borges, K.; Bowie, D.; Traynelis, S.F. The glutamate receptor ion channels. Pharmacol. Rev., 1999, 51(1), 7-61.
68. Egli, R.E.; Kash, T.L.; Choo, K.; Savchenko, V.; Matthews, R.T.; Blakely, R.D.; Winder, D.G. Norepinephrine modulates glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropsychopharmacology, 2005, 30(4), 657-668.
69. Egli, R.E.; Winder, D.G. Dorsal and ventral distribution of excitable and synaptic properties of neurons of the bed nucleus of the stria terminalis. J.Neurophysiol., 2003, 90(1), 405-414.
70. Forray, M.I.; Gysling, K. Role of noradrenergic projections to the bed nucleus of the stria terminalis in the regulation of the hypothalamic-pituitary-adrenal axis. Brain Res. Brain Res. Rev., 2004, 47(1-3), 145-160.
71. Weitlauf, C.; Egli, R.E.; Grueter, B.A.; Winder, D.G. Highfrequency stimulation induces ethanol-sensitive long-term potentiation at glutamatergic synapses in the dorsolateral bed nucleus of the stria terminalis. J. Neurosci., 2004, 24(25), 5741-5747.
72. Alves, F.H.; Crestani, C.C.; Resstel, L.B.; Correa, F.M. Bed nucleus of the stria terminalis N-methyl-D-aspartate receptors and nitric oxide modulate the baroreflex cardiac component in unanesthetized rats. J. Neurosci. Res., 2009, 87(7), 1703-1711.
73. Massi, L.; Elezgarai, I.; Puente, N.; Reguero, L.; Grandes, P.; Manzoni, O.J.; Georges, F. Cannabinoid receptors in the bed nucleus of the stria terminalis control cortical excitation of midbrain dopamine cells in vivo. J. Neurosci., 2008, 28(42), 10496-10508.
74. Cullinan, W.E.; Herman, J.P.; Watson, S.J. Ventral subicular interaction with the hypothalamic paraventricular nucleus: evidence for a relay in the bed nucleus of the stria terminalis. J. Comp. Neurol., 1993, 332(1), 1-20.
75. Gelsema, A.J.; Calaresu, F.R. Chemical microstimulation of the septal area lowers arterial pressure in the rat. Am. J. Physiol., 1987, 252(4 Pt 2), R760-767.
76. Giancola, S.B.; Roder, S.; Ciriello, J. Contribution of caudal ventrolateral medulla to the cardiovascular responses elicited by activation of bed nucleus of the stria terminalis. Brain Res., 1993, 606(1), 162-166.
77. Sved, A.F.; Ito, S.; Madden, C.J. Baroreflex dependent and independent roles of the caudal ventrolateral medulla in cardiovascular regulation. Brain Res. Bull., 2000, 51(2), 129-133.
78. Bowery, N.G.; Bettler, B.; Froestl, W.; Gallagher, J.P.; Marshall, F.; Raiteri, M.; Bonner, T.I.; Enna, S.J. International Union of Pharmacology. XXXIII. Mammalian gamma-aminobutyric acid(B) receptors: structure and function. Pharmacol. Rev., 2002, 54(2), 247-264.
79. Olsen, R.W.; Sieghart, W. International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol. Rev.,2008, 60(3), 243-260.
80. Sun, N.; Cassell, M.D. Intrinsic GABAergic neurons in the rat central extended amygdala. J. Comp. Neurol., 1993, 330(3), 381-404.
81. Swanson, L.W.; Petrovich, G.D. What is the amygdala? Trends Neurosci., 1998, 21(8), 323-331.
82. Hatam, M.; Kharazmi, F.; Nasimi, A. Vasopressin and sympathetic systems mediate the cardiovascular effects of the GABAergic system in the bed nucleus of the stria terminalis. Neurosci. Res., 2009, 65(4), 347-352.
83. Sajdyk, T.; Johnson, P.; Fitz, S.; Shekhar, A. Chronic inhibition of GABA synthesis in the bed nucleus of the stria terminalis elicits anxiety-like behavior. J. Psychopharmacol., 2008, 22(6), 633-641.
84. Ahlquist, R.P. A study of the adrenotropic receptors. Am. J. Physiol., 1948, 153(3), 586-600.
85. Bylund, D.B.; Eikenberg, D.C.; Hieble, J.P.; Langer, S.Z.; Lefkowitz, R.J.; Minneman, K.P.; Molinoff, P.B.; Ruffolo, R.R., Jr.; Trendelenburg, U. International Union of Pharmacology nomenclature of adrenoceptors. Pharmacol. Rev., 1994, 46(2), 121-136.
86. Docherty, J.R. Subtypes of functional alpha1- and alpha2- adrenoceptors. Eur.J. Pharmacol., 1998, 361(1), 1-15.
87. Hieble, J.P. Subclassification and nomenclature of alpha- and betaadrenoceptors. Curr. Top. Med. Chem., 2007, 7(2), 129-134.
88. Hieble, J.P.; Bylund, D.B.; Clarke, D.E.; Eikenburg, D.C.; Langer, S.Z.; Lefkowitz, R.J.; Minneman, K.P.; Ruffolo, R.R., Jr. International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol. Rev., 1995, 47(2), 267-270.
89. Kilts, C.D.; Anderson, C.M. The simultaneous quantification of dopamine, norepinephrine and epinephrine in micropunched rat brain nuclei by on-line trace enrichment HPLC with electrochemical detection: Distribution of catecholamines in the limbic system. Neurochem. Int., 1986, 9(3), 437-445.
90. Swanson, L.W.; Hartman, B.K. The central adrenergic system. An immunofluorescence study of the location of cell bodies and their efferent connections in the rat utilizing dopamine-beta-hydroxylase as a marker. J. Comp. Neurol., 1975, 163(4), 467-505.
91. Fuentealba, J.A.; Forray, M.I.; Gysling, K. Chronic morphine treatment and withdrawal increase extracellular levels of norepinephrine in the rat bed nucleus of the stria terminalis. J. Neurochem., 2000, 75(2), 741-748.
92. Byrum, C.E.; Guyenet, P.G. Afferent and efferent connections of the A5 noradrenergic cell group in the rat. J. Comp. Neurol., 1987, 261(4), 529-542.
93. Forray, M.I.; Gysling, K.; Andres, M.E.; Bustos, G.; Araneda, S. Medullary noradrenergic neurons projecting to the bed nucleus of the stria terminalis express mRNA for the NMDA-NR1 receptor. Brain Res. Bull., 2000, 52(3), 163-169.
94. Moore, R.Y. Catecholamin innervation of the basal forebrain. I. The septal area. J. Comp. Neurol., 1978, 177(4), 665-684.
95. Riche, D.; De Pommery, J.; Menetrey, D. Neuropeptides and catecholamines in efferent projections of the nuclei of the solitary tract in the rat. J. Comp. Neurol., 1990, 293(3), 399-424.
96. Woulfe, J.M.; Flumerfelt, B.A.; Hrycyshyn, A.W. Efferent connections of the A1 noradrenergic cell group: a DBH immunohistochemical and PHA-L anterograde tracing study. Exp. Neurol., 1990, 109(3), 308-322.
97. Roder, S.; Ciriello, J. Collateral axonal projections to limbic structures from ventrolateral medullary A1 noradrenergic neurons. Brain Res., 1994, 638(1-2), 182-188.
98. Woulfe, J.M.; Hrycyshyn, A.W.; Flumerfelt, B.A. Collateral axonal projections from the A1 noradrenergic cell group to the paraventricular nucleus and bed nucleus of the stria terminalis in the rat. Exp. Neurol., 1988, 102(1), 121-124.
99. Dumont, E.C.; Williams, J.T. Noradrenaline triggers GABAA inhibition of bed nucleus of the stria terminalis neurons projecting to the ventral tegmental area. J. Neurosci., 2004, 24(38), 8198-8204.
100. Sawada, S.; Yamamoto, C. Postsynaptic inhibitory actions of catecholamines and opioid peptides in the bed nucleus of the stria terminalis. Exp. Brain Res., 1981, 41(3-4), 264-270.
101. Crestani, C.C.; Alves, F.H.; Resstel, L.B.; Correa, F.M. Cardiovascular effects of noradrenaline microinjection in the bed nucleus of the stria terminalis of the rat brain. J. Neurosci. Res., 2007, 85(7), 1592-1599.
102. Crestani, C.C.; Alves, F.H.; Resstel, L.B.; Correa, F.M. Both alpha1 and alpha2-adrenoceptors mediate the cardiovascular responses to noradrenaline microinjected into the bed nucleus of the stria terminal of rats. Br. J. Pharmacol., 2008, 153(3), 583-590.
103. Crestani, C.C.; Alves, F.H.; Resstel, L.B.; Correa, F.M. Bed nucleus of the stria terminalis alpha(1)-adrenoceptor modulates baroreflex cardiac component in unanesthetized rats. Brain Res., 2008, 1245, 108-115.
104. Forray, M.I.; Bustos, G.; Gysling, K. Regulation of norepinephrine release from the rat bed nucleus of the stria terminalis: in vivo microdialysis studies. J. Neurosci. Res., 1997, 50(6), 1040-1046.
105. Caulfield, M.P. Muscarinic receptors--characterization, coupling and function. Pharmacol. Ther., 1993, 58(3), 319-379.
106. Caulfield, M.P.; Birdsall, N.J. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacol. Rev., 1998, 50(2), 279-290.
107. Gay, E.A.; Yakel, J.L. Gating of nicotinic ACh receptors; new insights into structural transitions triggered by agonist binding that induce channel opening. J. Physiol., 2007, 584(Pt 3), 727-733.
108. Clarke, P.B.; Schwartz, R.D.; Paul, S.M.; Pert, C.B.; Pert, A. Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. J. Neurosci., 1985, 5(5), 1307-1315.
109. Wamsley, J.K.; Zarbin, M.A.; Kuhar, M.J. Distribution of muscarinic cholinergic high and low affinity agonist binding sites: a light microscopic autoradiographic study. Brain Res. Bull., 1984, 12(3), 233-243.
110. Casada, J.H.; Dafny, N. Muscarinic receptors mediate the effect of acetylcholine (ACh) on neurons of the bed nucleus of the stria terminalis (BNST). Brain Res., 1993, 631(1), 124-128.
111. Woolf, N.J.; Butcher, L.L. Cholinergic systems in the rat brain: III. Projections from the pontomesencephalic tegmentum to the thalamus, tectum, basal ganglia, and basal forebrain. Brain Res. Bull., 1986, 16(5), 603-637.
112. Alves, F.H.; Crestani, C.C.; Resstel, L.B.; Correa, F.M. Cardiovascular effects of carbachol microinjected into the bed nucleus of the stria terminalis of the rat brain. Brain Res., 2007, 1143, 161-168.
113. Bredt, D.S. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic. Res., 1999, 31(6), 577-596.
114. Ignarro, L.J.; Buga, G.M.; Wood, K.S.; Byrns, R.E.; Chaudhuri, G. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. U. S. A., 1987, 84(24), 9265-9269.
115. Palmer, R.M.; Ferrige, A.G.; Moncada, S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature, 1987, 327(6122), 524-526.
116. Furchgott, R.F.; Zawadzki, J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature, 1980, 288(5789), 373-376.
117. Garthwaite, J. Concepts of neural nitric oxide-mediated transmission. Eur. J. Neurosci., 2008, 27(11), 2783-2802.
118. Alderton, W.K.; Cooper, C.E.; Knowles, R.G. Nitric oxide synthases: structure, function and inhibition. Biochem. J., 2001, 357(Pt 3), 593-615.
119. Prast, H.; Philippu, A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol., 2001, 64(1), 51-68.
120. Huang, P.L.; Dawson, T.M.; Bredt, D.S.; Snyder, S.H.; Fishman, M.C. Targeted disruption of the neuronal nitric oxide synthase gene. Cell, 1993, 75(7), 1273-1286.
121. Garthwaite, J.; Charles, S.L.; Chess-Williams, R. Endotheliumderived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature, 1988, 336(6197), 385-388.
122. Zhou, L.; Zhu, D.Y. Neuronal nitric oxide synthase: structure, subcellular localization, regulation, and clinical implications. Nitric Oxide, 2009, 20(4), 223-230.
123. Amitai, Y. Physiologic role for inducible nitric oxide synthase: a new form of astrocytic-neuronal interface. Glia, 2010, 58(15), 1775-1781.
124. Dinerman, J.L.; Dawson, T.M.; Schell, M.J.; Snowman, A.; Snyder, S.H. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: implications for synaptic plasticity. Proc. Natl. Acad. Sci. U. S. A., 1994, 91(10), 4214-4218.
125. Piomelli, D. The molecular logic of endocannabinoid signalling. Nat. Rev. Neurosci., 2003, 4(11), 873-884.
126. Howlett, A.C.; Barth, F.; Bonner, T.I.; Cabral, G.; Casellas, P.; Devane, W.A.; Felder, C.C.; Herkenham, M.; Mackie, K.; Martin, B.R.; Mechoulam, R.; Pertwee, R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev., 2002, 54(2), 161-202.
127. Puente, N.; Elezgarai, I.; Lafourcade, M.; Reguero, L.; Marsicano, G.; Georges, F.; Manzoni, O.J.; Grandes, P. Localization and function of the cannabinoid CB1 receptor in the anterolateral bed nucleus of the stria terminalis. PLoS One, 2010, 5(1), e8869.
128. Schlicker, E.; Kathmann, M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci., 2001, 22(11), 565-572.
129. Matsuda, L.A.; Bonner, T.I.; Lolait, S.J. Localization of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol., 1993, 327(4), 535-550.
130. Tsou, K.; Brown, S.; Sanudo-Pena, M.C.; Mackie, K.; Walker, J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience, 1998, 83(2), 393-411.
131. Lemos, J.I.; Resstel, L.B.; Guimaraes, F.S. Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats. Behav. Brain Res., 2010, 207(1), 105-111.
132. Gomes, F.V.; Reis, D.G.; Alves, F.H.; Correa, F.M.; Guimaraes, F.S.; Resstel, L.B. Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors. J. Psychopharmacol., 2012, 26(1), 104-113.
133. Gomes, F.V.; Alves, F.H.; Guimaraes, F.S.; Correa, F.M.; Resstel, L.B.; Crestani, C.C. Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT1A receptor. Eur Neuropsychopharmacol, 2012, doi: 10.1016/j.euroneuro.2012.09. 007.
134. Gomes, F.V.; Resstel, L.B.; Guimaraes, F.S. The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors. Psychopharmacology (Berl), 2011, 213(2-3), 465-473.
135. Alves, F.H.; Crestani, C.C.; Gomes, F.V.; Guimaraes, F.S.; Correa, F.M.; Resstel, L.B. Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors. Pharmacol. Res., 2010, 62(3), 228-236.
136. Thomas, B.F.; Gilliam, A.F.; Burch, D.F.; Roche, M.J.; Seltzman, H.H. Comparative receptor binding analyses of cannabinoid agonists and antagonists. J. Pharmacol. Exp. Ther., 1998, 285(1), 285-292.
137. Bisogno, T.; Hanus, L.; De Petrocellis, L.; Tchilibon, S.; Ponde, D.E.; Brandi, I.; Moriello, A.S.; Davis, J.B.; Mechoulam, R.; Di Marzo, V. Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide. Br. J. Pharmacol., 2001, 134(4), 845-852.
138. Mechoulam, R.; Parker, L.A.; Gallily, R. Cannabidiol: an overview of some pharmacological aspects. J. Clin. Pharmacol., 2002, 42(11 Suppl), 11S-19S.
139. Carrier, E.J.; Auchampach, J.A.; Hillard, C.J. Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression. Proc. Natl. Acad. Sci. U. S. A., 2006, 103(20), 7895-7900.
140. Yang, K.H.; Galadari, S.; Isaev, D.; Petroianu, G.; Shippenberg, T.S.; Oz, M. The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes. J. Pharmacol. Exp. Ther., 2010, 333(2), 547-554.
141. Russo, E.B.; Burnett, A.; Hall, B.; Parker, K.K. Agonistic properties of cannabidiol at 5-HT1a receptors. Neurochem. Res., 2005, 30(8), 1037-1043.
142. Commons, K.G.; Connolley, K.R.; Valentino, R.J. A neurochemically distinct dorsal raphe-limbic circuit with a potential role in affective disorders. Neuropsychopharmacology, 2003, 28(2), 206-215.
143. Lowry, C.A.; Hale, M.W.; Evans, A.K.; Heerkens, J.; Staub, D.R.; Gasser, P.J.; Shekhar, A. Serotonergic systems, anxiety, and affective disorder: focus on the dorsomedial part of the dorsal raphe nucleus. Ann. N. Y. Acad. Sci., 2008, 1148, 86-94.
144. Guo, J.D.; Hammack, S.E.; Hazra, R.; Levita, L.; Rainnie, D.G. Bidirectional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes. Neuroscience, 2009, 164(4), 1776-1793.
145. Levita, L.; Hammack, S.E.; Mania, I.; Li, X.Y.; Davis, M.; Rainnie, D.G. 5-hydroxytryptamine1A-like receptor activation in the bed nucleus of the stria terminalis: electrophysiological and behavioral studies. Neuroscience, 2004, 128(3), 583-596.
146. Rainnie, D.G. Neurons of the bed nucleus of the stria terminalis (BNST). Electrophysiological properties and their response to serotonin. Ann. N. Y. Acad. Sci., 1999, 877, 695-699.
147. Vale, W.; Spiess, J.; Rivier, C.; Rivier, J. Characterization of a 41- residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science, 1981, 213(4514), 1394-1397.
148. Bale, T.L.; Vale, W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol., 2004, 44, 525-557.
149. Coste, S.C.; Quintos, R.F.; Stenzel-Poore, M.P. Corticotropinreleasing hormone-related peptides and receptors: emergent regulators of cardiovascular adaptations to stress. Trends Cardiovasc. Med., 2002, 12(4), 176-182.
150. Inoue, K.; Valdez, G.R.; Reyes, T.M.; Reinhardt, L.E.; Tabarin, A.; Rivier, J.; Vale, W.W.; Sawchenko, P.E.; Koob, G.F.; Zorrilla, E.P. Human urocortin II, a selective agonist for the type 2 corticotropinreleasing factor receptor, decreases feeding and drinking in the rat. J. Pharmacol. Exp. Ther., 2003, 305(1), 385-393.
151. Koob, G.F.; Heinrichs, S.C. A role for corticotropin releasing factor and urocortin in behavioral responses to stressors. Brain Res., 1999, 848(1-2), 141-152.
152. Stengel, A.; Tache, Y. Corticotropin-releasing factor signaling and visceral response to stress. Exp. Biol. Med. (Maywood), 2010, 235(10), 1168-1178.
153. Thorsell, A. Brain neuropeptide Y and corticotropin-releasing hormone in mediating stress and anxiety. Exp. Biol. Med. (Maywood), 2010, 235(10), 1163-1167.
154. Hauger, R.L.; Grigoriadis, D.E.; Dallman, M.F.; Plotsky, P.M.; Vale, W.W.; Dautzenberg, F.M. International Union of Pharmacology. XXXVI. Current status of the nomenclature for receptors for corticotropin-releasing factor and their ligands. Pharmacol. Rev. 2003, 55(1), 21-26.
155. Phelix, C.F.; Paull, W.K. Demonstration of distinct corticotropin releasing factor--containing neuron populations in the bed nucleus of the stria terminalis. A light and electron microscopic immunocytochemical study in the rat. Histochemistry, 1990, 94(4), 345-364.
156. Swanson, L.W.; Sawchenko, P.E.; Rivier, J.; Vale, W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology, 1983, 36(3), 165-186.
157. Sakanaka, M.; Shibasaki, T.; Lederis, K. Distribution and efferent projections of corticotropin-releasing factor-like immunoreactivity in the rat amygdaloid complex. Brain Res., 1986, 382(2), 213-238.
158. Chalmers, D.T.; Lovenberg, T.W.; De Souza, E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci., 1995, 15(10), 6340-6350.
159. Reul, J.M.; Holsboer, F. Corticotropin-releasing factor receptors 1 and 2 in anxiety and depression. Curr. Opin. Pharmacol., 2002, 2(1), 23-33.
160. Arnold, F.J.; De Lucas Bueno, M.; Shiers, H.; Hancock, D.C.; Evan, G.I.; Herbert, J. Expression of c-fos in regions of the basal limbic forebrain following intracerebroventricular corticotropinreleasing factor in unstressed or stressed male rats. Neuroscience, 1992, 51(2), 377-390.
161. Chappell, P.B.; Smith, M.A.; Kilts, C.D.; Bissette, G.; Ritchie, J.; Anderson, C.; Nemeroff, C.B. Alterations in corticotropin-releasing factor-like immunoreactivity in discrete rat brain regions after acute and chronic stress. J. Neurosci., 1986, 6(10), 2908-2914.
162. Sink, K.S.; Walker, D.L.; Freeman, S.M.; Flandreau, E.I.; Ressler, K.J.; Davis, M. Effects of continuously enhanced corticotropin releasing factor expression within the bed nucleus of the stria terminalis on conditioned and unconditioned anxiety. Mol. Psychiatry, 2012.
163. Walker, D.L.; Miles, L.A.; Davis, M. Selective participation of the bed nucleus of the stria terminalis and CRF in sustained anxietylike versus phasic fear-like responses. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2009, 33(8), 1291-1308.
164. Nijsen, M.J.; Croiset, G.; Diamant, M.; De Wied, D.; Wiegant, V.M. CRH signalling in the bed nucleus of the stria terminalis is involved in stress-induced cardiac vagal activation in conscious rats. Neuropsychopharmacology, 2001, 24(1), 1-10.
165. Swaab, D.F.; Nijveldt, F.; Pool, C.W. Distribution of oxytocin and vasopressin in the rat supraoptic and paraventricular nucleus. J. Endocrinol., 1975, 67(3), 461-462.
166. Leng, G.; Brown, C.H.; Russell, J.A. Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog. Neurobiol., 1999, 57(6), 625-655.
167. Gimpl, G.; Fahrenholz, F. The oxytocin receptor system: structure, function, and regulation. Physiol. Rev., 2001, 81(2), 629-683.
168. Gutkowska, J.; Jankowski, M. Oxytocin revisited: its role in cardiovascular regulation. J. Neuroendocrinol., 2012, 24(4), 599-608.
169. Tom, N.; Assinder, S.J. Oxytocin in health and disease. Int. J. Biochem. Cell Biol., 2010, 42(2), 202-205.
170. Holmes, C.L.; Landry, D.W.; Granton, J.T. Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology. Crit. Care, 2004, 8(1), 15-23.
171. Treschan, T.A.; Peters, J. The vasopressin system: physiology and clinical strategies. Anesthesiology, 2006, 105(3), 599-612. quiz 639-540.
172. Swanson, L.W.; Kuypers, H.G. The paraventricular nucleus of the hypothalamus: cytoarchitectonic subdivisions and organization of projections to the pituitary, dorsal vagal complex, and spinal cord as demonstrated by retrograde fluorescence double-labeling methods. J. Comp. Neurol., 1980, 194(3), 555-570.
173. Swanson, L.W.; Sawchenko, P.E.; Wiegand, S.J.; Price, J.L. Separate neurons in the paraventricular nucleus project to the median eminence and to the medulla or spinal cord. Brain Res., 1980, 198(1), 190-195.
174. Dong, H.W.; Swanson, L.W. Projections from bed nuclei of the stria terminalis, anteromedial area: cerebral hemisphere integration of neuroendocrine, autonomic, and behavioral aspects of energy balance. J. Comp. Neurol., 2006, 494(1), 142-178.
175. Herman, J.P.; Cullinan, W.E.; Watson, S.J. Involvement of the bed nucleus of the stria terminalis in tonic regulation of paraventricular hypothalamic CRH and AVP mRNA expression. J. Neuroendocrinol., 1994, 6(4), 433-442.
176. Choi, D.C.; Evanson, N.K.; Furay, A.R.; Ulrich-Lai, Y.M.; Ostrander, M.M.; Herman, J.P. The anteroventral bed nucleus of the stria terminalis differentially regulates hypothalamic-pituitaryadrenocortical axis responses to acute and chronic stress. Endocrinology, 2008, 149(2), 818-826.
177. Choi, D.C.; Furay, A.R.; Evanson, N.K.; Ulrich-Lai, Y.M.; Nguyen, M.M.; Ostrander, M.M.; Herman, J.P. The role of the posterior medial bed nucleus of the stria terminalis in modulating hypothalamic-pituitary-adrenocortical axis responsiveness to acute and chronic stress. Psychoneuroendocrinology, 2008, 33(5), 659-669.
178. Crane, J.W.; Buller, K.M.; Day, T.A. Evidence that the bed nucleus of the stria terminalis contributes to the modulation of hypophysiotropic corticotropin-releasing factor cell responses to systemic interleukin-1beta. J. Comp. Neurol., 2003, 467(2), 232-242.
179. Radley, J.J.; Sawchenko, P.E. A common substrate for prefrontal and hippocampal inhibition of the neuroendocrine stress response. J. Neurosci., 2011, 31(26), 9683-9695.
180. Rinaman, L. Hindbrain noradrenergic A2 neurons: diverse roles in autonomic, endocrine, cognitive, and behavioral functions. Am. J. Physiol. Regul. Integr. Comp. Physiol., 2011, 300(2), R222-235.
181. Banihashemi, L.; Rinaman, L. Noradrenergic inputs to the bed nucleus of the stria terminalis and paraventricular nucleus of the hypothalamus underlie hypothalamic-pituitary-adrenal axis but not hypophagic or conditioned avoidance responses to systemic yohimbine. J. Neurosci., 2006, 26(44), 11442-11453.
182. Forray, M.I.; Bustos, G.; Gysling, K. Noradrenaline inhibits glutamate release in the rat bed nucleus of the stria terminalis: in vivo microdialysis studies. J. Neurosci. Res., 1999, 55(3), 311-320.
183. Shields, A.D.; Wang, Q.; Winder, D.G. alpha2A-adrenergic receptors heterosynaptically regulate glutamatergic transmission in the bed nucleus of the stria terminalis. Neuroscience, 2009, 163(1), 339-351.
184. Shughrue, P.J.; Lane, M.V.; Merchenthaler, I. Comparative distribution of estrogen receptor-alpha and -beta mRNA in the rat central nervous system. J. Comp. Neurol., 1997, 388(4), 507-525.
185. Simerly, R.B.; Chang, C.; Muramatsu, M.; Swanson, L.W. Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study. J. Comp. Neurol., 1990, 294(1), 76-95.
186. Williamson, M.; Viau, V. Androgen receptor expressing neurons that project to the paraventricular nucleus of the hypothalamus in the male rat. J. Comp. Neurol., 2007, 503(6), 717-740.
187. Bingham, B.; Myung, C.; Innala, L.; Gray, M.; Anonuevo, A.; Viau, V. Androgen receptors in the posterior bed nucleus of the stria terminalis increase neuropeptide expression and the stressinduced activation of the paraventricular nucleus of the hypothalamus. Neuropsychopharmacology, 2011, 36(7), 1433-1443.
188. Harlan, R.E.; Shivers, B.D.; Romano, G.J.; Howells, R.D.; Pfaff, D.W. Localization of preproenkephalin mRNA in the rat brain and spinal cord by in situ hybridization. J. Com. Neurol., 1987, 258(2), 159-184.
189. Ikeda, K.; Watanabe, M.; Ichikawa, T.; Kobayashi, T.; Yano, R.; Kumanishi, T. Distribution of prepro-nociceptin/orphanin FQ mRNA and its receptor mRNA in developing and adult mouse central nervous systems. J. Comp. Neurol., 1998, 399(1), 139-151.
190. Piggins, H.D.; Stamp, J.A.; Burns, J.; Rusak, B.; Semba, K. Distribution of pituitary adenylate cyclase activating polypeptide (PACAP) immunoreactivity in the hypothalamus and extended amygdala of the rat. J. Comp. Neurol., 1996, 376(2), 278-294.
191. Green, M.K.; Barbieri, E.V.; Brown, B.D.; Chen, K.W.; Devine, D.P. Roles of the bed nucleus of stria terminalis and of the amygdala in N/OFQ-mediated anxiety and HPA axis activation. Neuropeptides, 2007, 41(6), 399-410.
192. Dawe, K.L.; Wakerley, J.B.; Fulford, A.J. Nociceptin/orphanin FQ and the regulation of neuronal excitability in the rat bed nucleus of the stria terminalis: interaction with glucocorticoids. Stress, 2010, 13(6), 516-527.
193. Khoshbouei, H.; Cecchi, M.; Morilak, D.A. Modulatory effects of galanin in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuropsychopharmacology, 2002, 27(1), 25-34.
194. Grinevich, V.; Fournier, A.; Pelletier, G. Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on corticotropin-releasing hormone (CRH) gene expression in the rat hypothalamic paraventricular nucleus. Brain Res., 1997, 773(1-2), 190-196.
195. Hammack, S.E.; Cheung, J.; Rhodes, K.M.; Schutz, K.C.; Falls, W.A.; Braas, K.M.; May, V. Chronic stress increases pituitary adenylate cyclase-activating peptide (PACAP) and brain-derived neurotrophic factor (BDNF) mRNA expression in the bed nucleus of the stria terminalis (BNST): roles for PACAP in anxiety-like behavior. Psychoneuroendocrinology, 2009, 34(6), 833-843.
196. Altura, B.M.; Altura, B.T. Actions of vasopressin, oxytocin, and synthetic analogs on vascular smooth muscle. Fed. Proc., 1984, 43(1), 80-86.
197. Fernandes, K.B.; Crippa, G.E.; Tavares, R.F.; Antunes-Rodrigues, J.; Correa, F.M. Mechanisms involved in the pressor response to noradrenaline injection into the cingulate cortex of unanesthetized rats. Neuropharmacology, 2003, 44(6), 757-763.
198. Crestani, C.C.; Busnardo, C.; Tavares, R.F.; Alves, F.H.; Correa, F.M. Involvement of hypothalamic paraventricular nucleus non-Nmethyl- D-aspartate receptors in the pressor response to noradrenaline microinjected into the bed nucleus of the stria terminalis of unanesthetized rats. Eur. J. Neurosci., 2009, 29(11), 2166-2176.
199. Ulrich-Lai, Y.M.; Jones, K.R.; Ziegler, D.R.; Cullinan, W.E.; Herman, J.P. Forebrain origins of glutamatergic innervation to the rat paraventricular nucleus of the hypothalamus: differential inputs to the anterior versus posterior subregions. J. Comp. Neurol., 2011, 519(7), 1301-1319.
200. Alves, F.H.; Crestani, C.C.; Busnardo, C.; Antunes-Rodrigues, J.; Gomes, F.V.; Resstel, L.B.; Correa, F.M. Hypothalamic supraoptic but not paraventricular nucleus is involved in cardiovascular responses to carbachol microinjected into the bed nucleus of stria terminalis of unanesthetized rats. Brain Res., 2011, 1393, 31-43.
201. Herman, J.P.; Ostrander, M.M.; Mueller, N.K.; Figueiredo, H. Limbic system mechanisms of stress regulation: hypothalamopituitary- adrenocortical axis. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2005, 29(8), 1201-1213.
202. Scopinho, A.A.; Resstel, L.B.; Antunes-Rodrigues, J.; Correa, F.M. Pressor effects of noradrenaline injected into the lateral septal area of unanesthetized rats. Brain Res., 2006, 1122(1), 126-134.
203. Scopinho, A.A.; Tavares, R.F.; Busnardo, C.; Correa, F.M. Non-Nmethyl- D-aspartate glutamate receptors in the paraventricular nucleus of hypothalamus mediate the pressor response evoked by noradrenaline microinjected into the lateral septal area in rats. J. Neurosci. Res., 2008, 86(14), 3203-3211.
204. Tavares, R.F.; Fernandes, K.B.; Pajolla, G.P.; Nascimento, I.A.; Correa, F.M. Neural connections between prosencephalic structures involved in vasopressin release. Cell Mol. Neurobiol., 2005, 25(3-4), 663-672.
205. Scopinho, A.A.; Aguiar, D.C.; Resstel, L.B.; Guimaraes, F.S.; Correa, F.M. Brain Pathways Involved in the Modulatory Effects of Noradrenaline in Lateral Septal Area on Cardiovascular Responses. Cell Mol. Neurobiol., 2012, 32(7), 1147-1157.
206. Scopinho, A.A.; Fortaleza, E.A.; Correa, F.M. The medial amygdaloid nucleus is involved in the cardiovascular pathway activated by noradrenaline into the lateral septal area of rats. Eur. J. Neurosci., 2012, 36(8), 3059-65.
207. Fortaleza, E.A.; Scopinho, A.A.; Correa, F.M. Cardiovascular responses to microinjection of noradrenaline into the medial amygdaloid nucleus of conscious rats result from alpha(2)-receptor activation and vasopressin release. Eur. J. Neurosci., 2011, 33(9), 1677-1684.
208. Guo, J.D.; Hazra, R.; Dabrowska, J.; Muly, E.C.; Wess, J.; Rainnie, D.G. Presynaptic muscarinic M(2) receptors modulate glutamatergic transmission in the bed nucleus of the stria terminalis. Neuropharmacology, 2012, 62(4), 1671-1683.
209. Guo, J.D.; Rainnie, D.G. Presynaptic 5-HT(1B) receptor-mediated serotonergic inhibition of glutamate transmission in the bed nucleus of the stria terminalis. Neuroscience, 2010, 165(4), 1390-1401.